Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Basic science, rationale, background and future of abatacept

Highly Access

Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?

Vivianne Malmström*, Christina Trollmo and Lars Klareskog

Arthritis Research & Therapy 2005, 7(Suppl 2):S15-S20 doi:10.1186/ar1505

Accesses  

  • Last 30 days: 41 accesses
  • Last 365 days: 478 accesses
  • All time: 7173 accesses

Cited by

BioMed Central: 2 citations